Lower Alzheimer Risk Seen With PDE5i Initiation for Erectile Dysfunction

WEDNESDAY, Feb. 7, 2024 -- For men with erectile dysfunction (ED), phosphodiesterase type 5 inhibitor (PDE5i) initiation is associated with a lower risk for Alzheimer disease (AD), according to a study published online Feb. 7 in Neurology.Matthew...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news